Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Columbia University
City of Hope Medical Center
Canadian Cancer Trials Group
Gustave Roussy, Cancer Campus, Grand Paris
Duke University
Duke University
Dartmouth-Hitchcock Medical Center
City of Hope Medical Center